Mesa Laboratories Inc MLAB:NASDAQ

Last Price$196.14NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22

Today's Change+5.50(2.89%)
Bid (Size)N/A (N/A)
Ask (Size)N/A (N/A)
Day Low / High$190.00 - 196.50
Volume51.1 K

View Medical Specialties IndustryPeer Comparison as of 08/12/2022


Mesa Laboratories Inc ( NASDAQ )

Price: $196.14
Change: +5.50 (2.89%)
Volume: 51.1 K
4:00PM ET 8/12/2022

Alphatec Holdings Inc ( NASDAQ )

Price: $9.62
Change: +0.71 (7.97%)
Volume: 706.7 K
4:00PM ET 8/12/2022

Cutera Inc ( NASDAQ )

Price: $50.70
Change: +1.75 (3.58%)
Volume: 181.4 K
4:00PM ET 8/12/2022

OrthoPediatrics Corp ( NASDAQ )

Price: $55.06
Change: -1.84 (3.23%)
Volume: 120.7 K
4:00PM ET 8/12/2022

AngioDynamics Inc ( NASDAQ )

Price: $24.23
Change: -0.07 (0.29%)
Volume: 321.5 K
4:00PM ET 8/12/2022

Read more news Recent News

--Evercore ISI Lowers Mesa Laboratories Price Target to $180 From $200, Maintains In Line Rating
11:56AM ET 8/11/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (MLAB) MESA LABORATORIES Posts Q1 EPS $1.17
8:01AM ET 8/04/2022 MT Newswires


--Mesa Laboratories Maintains Dividend at $0.16/Share; Payable on Sept. 15 to Shareholders of Record on Aug. 31
3:07AM ET 7/07/2022 MT Newswires


Insider Sell: Mesa Laboratories
2:51PM ET 6/22/2022 MT Newswires

Gary M Owens, President and CEO, on June 17, 2022, sold 1,756 shares in Mesa Laboratories (MLAB) for $330,521. Following the Form 4 filing with the SEC,...

View all Commentary and Analysis

Mesa Laboratories, Inc. 2023 Q1 - Results - Earnings Call Presentation
11:00AM ET 8/06/2022 Seeking Alpha

Cryoport: Rapid Growth Is Great, But Shares Look Overpriced
11:13PM ET 7/29/2022 Seeking Alpha

RVT: 8% Dividend Yield With Upside To Valuation
4:52AM ET 4/04/2022 Seeking Alpha

Mesa Laboratories (MLAB) Acquires Agena Bioscience
2:55PM ET 9/17/2021 Seeking Alpha

Company Profile

Business DescriptionMesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO. View company web site for more details
Address12100 West 6th Avenue
Lakewood, Colorado 80228
Number of Employees347
Recent SEC Filing08/09/20224
ChairmanJohn James Sullivan
President, CEO, COO & DirectorGary M. Owens
CFO, Treasurer & Chief Accounting OfficerJohn V. Sakys
Vice President-Strategy & Corporate DevelopmentPeter Jung

Company Highlights

Price Open$192.32
Previous Close$190.64
52 Week Range$178.32 - 333.42
Market Capitalization$1.0 B
Shares Outstanding5.3 M
SectorHealth Technology
IndustryMedical Specialties
Current Dividend / Yield$0.16 / 0.33%
Dividend Ex-Date08/30/2022
Dividend Pay-Date09/15/2022
Dividend Yield 5 Year AverageN/A
Next Earnings Announcement11/03/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.11
Beta vs. S&P 500N/A
Revenue$103.1 M
Net Profit Margin-0.78%
Return on Equity-0.40%

Analyst Ratings as of 06/16/2022

Consensus RecommendationConsensus Icon
Powered by Factset